Product Description
Details
KIWOF

Praziquantel and Pyrantel Pamoate Chewable Tablets

COMPOSITION:

Each chewable tablet contains:

Praziquantel IP 20 mg

Pyrantel Pamoate IP 230 mg

Excipients q.s

INDICATIONS:

Kiwof is indicated for the treatment of Roundworms, Hookworms and Tapeworms in cats.

Worms controlled include:

Roundworms:

Toxocara cati,

Toxascaris leonina

Hookworms:

Ancylostoma tubaeforme,

Ancylostoma brazilense,

Uncinaria stenocephala

Tapeworms:

Dipylidium caninum

Taenia taeniaeformis

DOSAGE AND ADMINISTRATION:

The recommended dose rates are 57.5 mg/kg Pyrantel Pamoate and 5 mg/kg Praziquantel. This is equivalent to 1 tablet per 4 kg (9 lbs) bodyweight. The tablet should be given directly but if necessary can be disguised in food. Kiwof Tablets may be given directly by mouth or offered in a small amount of food. Do not withhold food from the cat prior to or after treatment. The tablets are scored into halves to enable a range of weights to be treated.

Dosage:

2 kg bodyweight – ½ tablet

2.1 to 4 kg bodyweight – 1 tablet

4 to 6 kg bodyweight – 1 ½ tablet

*Not intended for use in kittens less than 6 weeks of age.

Recommended treatments

Kittens: Treat at 6,8,10 and 12 weeks and then a monthly until 6 months of age, after that every 3 months or on veterinary advice.

Lactating queens: Should be treated concurrently with kittens.

Adults: Treat every 3 months or on veterinary advice.

CONTRAINDICATIONS, WARNINGS, ETC:

Do not use in pregnancy.

Not intended for use in kittens less than 6 weeks of age.

Do not use simultaneously with piperazine compounds.

In the interests of good hygiene, persons administering the tablets directly to the cat, or by adding them to the cat’s food, should wash their hands afterwards.

For animal treatment only.

KEEP OUT OF REACH OF CHILDREN

Do not remove tablets from strip packing until required for use. Any part used tablets should be discarded.

Safety:

Cats treated with 10 times the highest recommended dose have reported signs of vomiting and salivation without other adverse effects. A temporary loss in appetite and loose stools have been reported in some cats.

Disposal:

Disposal of any empty packaging and remaining product in the household refuse.

Further information:

In order to reduce the risk of reinfestation with the tapeworm Dipylidium caninum, appropriate control measures for the flea intermediate host should be undertaken. The product has been shown to be efficacious in the control of the tapeworm Joyeauxiella pasqualei, and is effective against Echinococcus multilocularis.

PRESENTATION: Strip blister of 4 tablets

For the use only of a Veterinary Medical Practitioner only, Hospital or Laboratory or a Farm